EWTX
Edgewise Therapeutics Inc
39.10$
-0.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.2% | -1.5% | +1.7% | +12.7% | +4.5% | -11.9% | +2.3% | +0.5% | +0.9% | +2.6% | +1.2% | – | |
| – | +13.0% | -5.5% | +7.2% | +31.7% | +12.5% | +17.1% | -14.6% | +4.6% | -407.7% | – | +7.4% | – | |
| – | -120.6% | – | – | -21.3% | +176.2% | -168.5% | – | – | – | -168.6% | – | – | |
| – | -64.8% | +84.5% | -25.6% | +135.3% | -47.3% | -83.9% | +13.6% | +78.0% | +105.6% | +42.1% | -87.7% | – | |
| – | +15.2% | -1,094.4% | – | -32.1% | -17.5% | +109.8% | -469.4% | – | +39.3% | -95.1% | +3,126.1% | – | |
| – | – | +355.0% | -99.2% | +70.7% | -13.1% | -23.2% | +8,367.4% | -99.1% | +139.6% | +206.2% | -174.6% | – | |
| – | +4,520.9% | -205.1% | – | -90.0% | -337.7% | – | -178.9% | – | +482.7% | -284.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.